{"id":99536,"date":"2025-08-21T14:41:08","date_gmt":"2025-08-21T14:41:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/99536\/"},"modified":"2025-08-21T14:41:08","modified_gmt":"2025-08-21T14:41:08","slug":"parexel-taps-jim-anthony-as-cco-and-president-parexel-biotech","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/99536\/","title":{"rendered":"Parexel Taps Jim Anthony as CCO and President, Parexel Biotech"},"content":{"rendered":"<p><a href=\"https:\/\/www.parexel.com\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Parexel<\/a>, a global clinical research organization (CRO), has appointed Jim Anthony to the expanded role of Chief Commercial Officer (CCO) and President, Parexel Biotech.<\/p>\n<p>As Chief Commercial Officer and President, Parexel Biotech, Anthony will oversee both biotech and pharmaceutical customer strategy and relationships globally, leveraging the company\u2019s suite of solutions and therapeutic expertise across Phase I-IV clinical development to accelerate and advance its life-changing therapies to market.<\/p>\n<p>\u201cOur industry and clinical development are ever-changing. Parexel\u2019s ability to evolve and innovate to deliver for our customers is more important than ever,\u201d said <a href=\"https:\/\/www.contractpharma.com\/breaking-news\/parexel-announces-ceo-transition\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Chief Executive Officer Peyton Howell<\/a>. \u201cThe addition of a Chief Commercial Officer further supports this strategic focus as we work to meet our customers\u2019 needs and accelerate our growth objectives. Jim is the ideal person for this expanded role as demonstrated by his exceptional leadership of Parexel Biotech, growing this business from its start in 2019 to where it stands today, contributing approximately half of Parexel\u2019s global revenue. We look forward to his continued leadership and contributions, building on and scaling this success across our entire commercial organization.\u201d<\/p>\n<p>Experience<\/p>\n<p>Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role. He joined Parexel in 2010 as Vice President, North America Business Development, and since that time has held various leadership roles of increasing responsibility, including Corporate Vice President, Enterprise Account Leader, where he directly managed two of the company\u2019s largest pharma customers, and Executive Vice President and Global Head, Parexel Biotech, before being appointed as President and Global Head, Parexel Biotech in 2023.<\/p>\n<p>\u201cI\u2019m honored to serve in this expanded leadership role at such a pivotal time for our customers and our company,\u201d said Anthony. \u201cBy looking more holistically across all of our customers \u2014 from large pharma to small, emerging and mid-sized biotechs \u2014 we\u2019re strongly positioned to fully leverage our strengths, respond to market challenges with greater agility and strengthen our overall approach to accelerate our growth.\u201d<\/p>\n<p>More Parexel News<\/p>\n<p>Earlier this year, Parexel appointed <a href=\"https:\/\/www.contractpharma.com\/breaking-news\/parexel-names-chief-medical-officer\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Charlotte Moser, MD, PhD, MBA as Chief Medical Officer<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Parexel, a global clinical research organization (CRO), has appointed Jim Anthony to the expanded role of Chief Commercial&hellip;\n","protected":false},"author":2,"featured_media":99537,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[4,450,451,3,452,453],"class_list":["post-99536","post","type-post","status-publish","format-standard","has-post-thumbnail","category-breaking-news","tag-breaking-news","tag-breakingnews","tag-headlines","tag-news","tag-top-stories","tag-topstories"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/99536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=99536"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/99536\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/99537"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=99536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=99536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=99536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}